
Roses, a high -ranking law firm, encourages Kyverna Therapeutics, Inc. investors, to secure the lawyer from an important period for the classification for securities

New York, New York -(Newsfile Corp. -26 January 2025) – WHY: The law firm Rosen, a law firm for investor rights, reminds the buyers of ordinary shares of Kyverna Therapeutics, Inc. (Nasdaq: Kytx) in accordance with the public offer of…